3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Tumors of the Gastrointestinal tract - Colon cancer -

Racial differences in cancer care still unexplained

Cancer • • Tumors of the Gastrointestinal tract • • Colon cancerMay 14, 08

Even though black patients and white patients with rectal cancer are equally likely to consult with an oncologist, blacks are less likely to undergo additional treatment after surgery, according to research findings posted online by the Journal of the National Cancer Institute.

The lower rates of radiation and chemotherapy partially explain why long-term survival after rectal cancer surgery is up to 20 percent lower for black patients than for white patients. Dr. Arden M. Morris, at the University of Michigan in Ann Arbor, and her colleagues hypothesized that blacks may not be referred as often to medical and radiation oncologists.

Using information from a large national database, the researchers identified 2,716 patients 66 years of age or older who had undergone surgery for stage II or III rectal cancer.

There was no significant difference between the 134 black patients and the 2,582 white patients in how frequently they consulted with medical or radiation oncologists.

However, black patients were less likely than white patients to undergo chemotherapy (54 percent vs 70 percent), radiation (74 percent vs 83 percent) or both (61 percent vs 77 percent).

The authors could identify no demographic, clinical, or physician characteristics to account for the differences in treatment.

Until strategies can be developed such as, improving patient and physician communications or distributing resources to settings where black patients are most likely to obtain care, “it is unlikely that racial disparities in the care of rectal and, possibly, other cancers will be improved in a meaningful way,” Morris and her associates conclude.

SOURCE: Journal of the National Cancer Institute, May 13, 2008.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site